Jordan Levy has served on our board of directors since January 23, 2024. Mr. Levy currently serves as a Managing Partner at SBNY (formerly SoftBank Capital NY) and Seed Capital Partners, an early stage Venture Capital Fund he co-founded in late 1999. SBNY is a venture capital fund specializing in mobile, social media, eCommerce and digital media investments in early stage technology companies. In addition, he serves as Co-Managing Partner of Z80 Labs, an Accelerator Fund created in 2013 in Buffalo NY to help kick-start the start-up ecosystem. Prior to co-founding Seed Capital Partners, he was co-founder of Upgrade Corporation of America and was President, co-CEO and co-Chair of its predecessor companies SOFTBANK Services Group and ClientLogic (now SITEL Worldwide). Previously, Jordan was Senior Vice President of Software Etc. (now GameStop GME:NASDAQ), a chain of computer and video game stores throughout the US. He was also Executive Vice President and co-founder of Software Distribution Services, (now known as Ingram Micro IM:NASDAQ). He started his career in Albany, New York where he worked in the New York State Senate and was actively involved in dozens of political campaigns. Mr. Levy currently serves on the board of directors of several technology companies including, Rebelmouse, Strategic Financial Solutions, and Take2. Until recently he served on the Boards of ACV Auctions, US Bitcoin (acquired by HUT8 HUT:NASDAQ), Synacor, Buzzfeed, WorkMarket (acquired by ADP), Fieldlens acquired by (WeWork), ZipList (acquired by Advance Newhouse), OMGPOP (acquired by Zynga), KickApps (acquired by KIT Digital), XO Soft (acquired by CA), HyperPublic (acquired by Groupon), Huffington Post (acquired by AOL) and VirginMega (acquired by Nike). He also serves on the Mount Sinai Medical Center Foundation Executive Committee in Miami, FL. Previously, he sat on the Board of Upstate New York Regional Advisory Board of the Federal Reserve Bank of New York, was a founding Director of Cobalt Networks prior to its acquisition by Sun Microsystems, and GT Interactive before it was acquired by Atari. Mr. Levy also served as the first non-Native American on the Board of Seneca Holdings, LLC, the business arm of the Seneca Nation of Indians. Mr. Levy holds a B.A. in Political Science from the State University of New York at Buffalo.
What is Jordan Levy's net worth?
The estimated net worth of Jordan Levy is at least $5.24 million as of March 6th, 2025. Levy owns 306,887 shares of Core Scientific stock worth more than $5,241,630 as of December 4th. This net worth approximation does not reflect any other assets that Levy may own. Learn More about Jordan Levy's net worth.
How do I contact Jordan Levy?
The corporate mailing address for Levy and other Core Scientific executives is 321 NORTH CLARK STREET SUITE 2440, CHICAGO IL, 60654. Core Scientific can also be reached via phone at 312-262-5642 and via email at https://investors.corescientific.com. Learn More on Jordan Levy's contact information.
Has Jordan Levy been buying or selling shares of Core Scientific?
Jordan Levy has not been actively trading shares of Core Scientific within the last three months. Most recently, on Thursday, March 6th, Jordan Levy bought 62,500 shares of Core Scientific stock. The stock was acquired at an average cost of $8.01 per share, with a total value of $500,625.00. Following the completion of the transaction, the director now directly owns 306,887 shares of the company's stock, valued at $2,458,164.87. Learn More on Jordan Levy's trading history.
Who are Core Scientific's active insiders?
Are insiders buying or selling shares of Core Scientific?
During the last year, Core Scientific insiders bought shares 3 times. They purchased a total of 177,500 shares worth more than $1,803,825.00. During the last year, insiders at the sold shares 9 times. They sold a total of 866,041 shares worth more than $12,369,537.99. The most recent insider tranaction occured on November, 4th when Director Eric Stanton Weiss bought 5,000 shares worth more than $107,500.00. Insiders at Core Scientific own 1.4% of the company.
Learn More about insider trades at Core Scientific. Information on this page was last updated on 11/4/2025.
